Methylation profiling

Dataset Information

0

Potential Epigenetic Biomarkers for Preeclampsia Preterm Birth and Preventative Medicine


ABSTRACT: Preterm birth has dramatically increased within the population (i.e., >10%) and preeclampsia is one of the most unanticipated sub-categories of preterm birth. No clinical parameter or biomarkers exists for preeclampsia preterm birth, except for high blood pressure toward the end of pregnancy. The current study investigates the potential use of epigenetic (DNA methylation) alterations as a preeclampsia biomarker. Non-preeclampsia term births were compared to preeclampsia preterm births to identify methylation differences. Buccal cell cheek swabs were used as a marker cell for systemic epigenetic alterations in the individuals. A total of 389 differential DNA methylation regions (DMRs) were identified and associated with the presence of preeclampsia. The DMRs were genome-wide and were predominantly low CpG density (<2 CpG/100 bp). In comparison with a previous preterm birth epigenetic biomarker there was a 15% (60 DMR) overlap, indicating the majority of the DMRs are unique for preeclampsia.

ORGANISM(S): Homo sapiens

PROVIDER: GSE259360 | GEO | 2025/04/22

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-03-09 | GSE194227 | GEO
2017-05-04 | E-GEOD-71123 | biostudies-arrayexpress
2022-08-02 | GSE209620 | GEO
2022-08-03 | GSE210318 | GEO
2014-08-28 | PXD001268 | Pride
2018-09-26 | GSE120458 | GEO
2017-05-04 | GSE71123 | GEO
| PRJNA1081361 | ENA
2015-12-22 | E-GEOD-74738 | biostudies-arrayexpress
2020-07-20 | GSE152380 | GEO